<div id="wc4uq"></div>
<small id="wc4uq"><div id="wc4uq"></div></small><small id="wc4uq"></small>
<small id="wc4uq"><wbr id="wc4uq"></wbr></small><div id="wc4uq"></div><small id="wc4uq"></small>
<xmp id="wc4uq"><label id="wc4uq"></label>
<div id="wc4uq"><wbr id="wc4uq"></wbr></div>
<xmp id="wc4uq"><div id="wc4uq"></div><wbr id="wc4uq"></wbr>
<div id="wc4uq"><wbr id="wc4uq"></wbr></div>
<div id="wc4uq"><button id="wc4uq"></button></div>


International Market

Hansoh actively implements the internationalization strategy and has been committed itself to human being’s health with its professional expertise, through sales of internationally certified APIs and finished-dose pharmaceutical products to  the U.S. and other countries, and  international multi-center clinical trials for innovative drugs.   

Market Internationalization 

Multiple finished-dose pharmaceutical products and APIs are sold to the global market. 

R&D Internationalization 

Global multi-center clinical trials are under way simultaneously in the U.S. and China for HS-10296, a Category 1.1 innovative oncology drug, amid efforts for global expansion of innovative drugs.